Disability in rheumatoid arthritis in the era of biological treatments

Annals of the Rheumatic Diseases

Volumn 71, Issue 2, 2012, Pages 213-218

  Krishnan, Eswar ^a   Lingala, Bharathi ^a   Bruce, Bonnie ^a   Fries, James F ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; BIOLOGICAL PRODUCT; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; HYDROXYCHLOROQUINE; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; PREDNISONE;

ADULT; AFRICAN AMERICAN; AGE; AGED; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DEATH; DISABILITY; DISEASE DURATION; EDUCATION; ETHNICITY; FEMALE; FOLLOW UP; GENDER; HEALTH ASSESSMENT QUESTIONNAIRE DISABILITY INDEX; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RATING SCALE; RHEUMATOID ARTHRITIS; SMOKING; STATISTICAL MODEL;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BIOLOGICAL AGENTS; BODY MASS INDEX; DISABILITY EVALUATION; DRUG UTILIZATION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; METHOTREXATE; MIDDLE AGED; PROSPECTIVE STUDIES; SMOKING; TREATMENT OUTCOME; UNITED STATES;

EID: 84855349340     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2011-200354     Document Type: Article

References (36)

1. Manton KG, Corder LS, Stallard E. Estimates of change in chronic disability and institutional incidence and prevalence rates in the US elderly population from the 1982, 1984, and 1989 National Long Term Care Survey. J Gerontol 1993;48:S153-66. (Pubitemid 23199256)
2. Freedman VA, Martin LG, Schoeni RF. Recent trends in disability and functioning among older adults in the United States: a systematic review. JAMA 2002;288:3137-46. (Pubitemid 36014131)
3. Krishnan E, Fries JF. Reduction in long-term functional disability in rheumatoid arthritis from 1977 to 1998: a longitudinal study of 3035 patients. Am J Med 2003;115:371-6. (Pubitemid 37311254)
4. Vita AJ, Terry RB, Hubert HB, et al. Aging, health risks, and cumulative disability. N Engl J Med 1998;338:1035-41. (Pubitemid 28180406)
5. Fries JF, Koop CE, Beadle CE, et al. Reducing health care costs by reducing the need and demand for medical services. The Health Project Consortium. N Engl J Med 1993;329:321-5. (Pubitemid 23210685)
6. Fries JF. Reevaluating the therapeutic approach to rheumatoid arthritis: the 'sawtooth' strategy. J Rheumatol Suppl 1990;22:12-15. (Pubitemid 20162907)
7. Ward MM. Trends in the use of disease modifying antirheumatic medications in rheumatoid arthritis, 1980-1995: results from the National Ambulatory Medical Care Surveys. J Rheumatol 1999;26:546-50. (Pubitemid 29125569)
8. Schmajuk G, Schneeweiss S, Katz JN, et al. Treatment of older adult patients diagnosed with rheumatoid arthritis: improved but not optimal. Arthritis Rheum 2007;57:928-34. (Pubitemid 47237318)
9. Fries JF, Murtagh KN, Bennett M, et al. The rise and decline of nonsteroidal antiinflammatory drug-associated gastropathy in rheumatoid arthritis. Arthritis Rheum 2004;50:2433-40. (Pubitemid 39062702)
10. Fries JF, Williams CA, Bloch DA. The relative toxicity of nonsteroidal anti-inflammatory drugs. Arthritis Rheum 1991;34:1353-60.
11. Fries JF, Williams CA, Ramey D, et al. The relative toxicity of disease-modifying antirheumatic drugs. Arthritis Rheum 1993;36:297-306. (Pubitemid 23090595)
12. Donahue KE, Gartlehner G, Jonas DE, et al. Systematic review: comparative effectiveness and harms of disease-modifying medications for rheumatoid arthritis. Ann Intern Med 2008;148:124-34. (Pubitemid 351651555)
13. Baka Z, Buzás E, Nagy G. Rheumatoid arthritis and smoking: putting the pieces together. Arthritis Res Ther 2009;11:238.
14. Krishnan E, Sokka T, Hannonen P. Smoking-gender interaction and risk for rheumatoid arthritis. Arthritis Res Ther 2003;5:R158-62.
15. Symmons DP, Bankhead CR, Harrison BJ, et al. Blood transfusion, smoking, and obesity as risk factors for the development of rheumatoid arthritis: results from a primary care-based incident case-control study in Norfolk, England. Arthritis Rheum 1997;40:1955-61. (Pubitemid 27494654)
16. Bruce B, Fries JF. The Arthritis, Rheumatism and Aging Medical Information System (ARAMIS): still young at 30 years. Clin Exp Rheumatol 2005;23(5 Suppl 39):S163-7. (Pubitemid 46657523)
17. Krishnan E, Murtagh K, Bruce B, et al. Attrition bias in rheumatoid arthritis databanks: a case study of 6346 patients in 11 databanks and 65,649 administrations of the Health Assessment Questionnaire. J Rheumatol 2004;31:1320-6. (Pubitemid 38879195)
18. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24. (Pubitemid 18091653)
19. Bruce B, Fries JF. The Stanford Health Assessment Questionnaire: a review of its history, issues, progress, and documentation. J Rheumatol 2003;30:167-78. (Pubitemid 36077790)
20. Ziegler S, Huscher D, Karberg K, et al. Trends in treatment and outcomes of rheumatoid arthritis in Germany 1997-2007: results from the National Database of the German Collaborative Arthritis Centres. Ann Rheum Dis 2010;69:1803-8.
21. Sokka T, Kautiainen H, Häkkinen A, et al. Radiographic progression is getting milder in patients with early rheumatoid arthritis. Results of 3 cohorts over 5 years. J Rheumatol 2004;31:1073-82. (Pubitemid 38715880)
22. Watts RA, Mooney J, Lane SE, et al. Rheumatoid vasculitis: becoming extinct? Rheumatology (Oxford) 2004;43:920-3. (Pubitemid 38996969)
23. Adler S, Spehr P, Allen J, et al. Chronic animal testing of new cardiac pacing electrodes. Pacing Clin Electrophysiol 1990;13:1896-900.
24. Kaipiainen-Seppanen O, Kautiainen H. Declining trend in the incidence of rheumatoid factor-positive rheumatoid arthritis in Finland 1980-2000. J Rheumatol 2006;33:2132-8. (Pubitemid 44749769)
25. Radovits BJ, Fransen J, Al Shamma S, et al. Excess mortality emerges after 10 years in an inception cohort of early rheumatoid arthritis. Arthritis Care Res (Hoboken) 2010;62:362-70.
26. Linos A, Worthington JW, O'Fallon WM, et al. The epidemiology of rheumatoid arthritis in Rochester, Minnesota: a study of incidence, prevalence, and mortality. Am J Epidemiol 1980;111:87-98. (Pubitemid 10207608)
27. Bergström U, Book C, Lindroth Y, et al. Lower disease activity and disability in Swedish patients with rheumatoid arthritis in 1995 compared with 1978. Scand J Rheumatol 1999;28:160-5. (Pubitemid 29298011)
28. Uhlig T, Heiberg T, Mowinckel P, et al. Rheumatoid arthritis is milder in the new millennium: health status in patients with rheumatoid arthritis 1994-2004. Ann Rheum Dis 2008;67:1710-15.
29. Finckh A, Choi HK, Wolfe F. Progression of radiographic joint damage in different eras: trends towards milder disease in rheumatoid arthritis are attributable to improved treatment. Ann Rheum Dis 2006;65:1192-7. (Pubitemid 44277395)
30. Ward MM, Fries JF. Trends in antirheumatic medication use among patients with rheumatoid arthritis, 1981-1996. J Rheumatol 1998;25:408-16. (Pubitemid 28109338)
31. National Center for Health Statistics. Health, United States 2009: With Special Feature on Medical Technology. Hyattsville, MD: National Center for Health Statistics, 2010.
32. Yazici Y, Shi N, John A. Utilization of biologic agents in rheumatoid arthritis in the United States: analysis of prescribing patterns in 16,752 newly diagnosed patients and patients new to biologic therapy. Bull NYU Hosp Jt Dis 2008;66:77-85. (Pubitemid 351898370)
33. Grijalva CG, Chung CP, Stein CM, et al. Changing patterns of medication use in patients with rheumatoid arthritis in a Medicaid population. Rheumatology (Oxford) 2008;47:1061-4. (Pubitemid 351865934)
34. Khanna R, Smith MJ. Utilization and costs of medical services and prescription medications for rheumatoid arthritis among recipients covered by a state Medicaid program: a retrospective, cross-sectional, descriptive, database analysis. Clin Ther 2007;29:2456-67. (Pubitemid 350298127)
35. Kristensen LE, Jakobsen AK, Bartels EM, et al. The number needed to treat for second-generation biologics when treating established rheumatoid arthritis: a systematic quantitative review of randomized controlled trials. Scand J Rheumatol 2011;40:1-7.
36. Sokka T, Kautiainen H, Pincus T, et al. Disparities in rheumatoid arthritis disease activity according to gross domestic product in 25 countries in the QUEST-RA database. Ann Rheum Dis 2009;68:1666-72.